Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer

Former Genentech CEO Ian Clark will guide Kyverna's vision to transform the treatment of autoimmune diseases through engineered cell therapies Seasoned pharmaceutical executive Karen Walker will lead technical development of Kyverna's T-cell therapies ... Biopharmaceuticals, Personnel Kyverna Therapeutics, cell therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news